Financial Times
On Extra Extra, Financial Times is grouped with center outlets, a placement drawn from the consensus of independent media-bias raters (AllSides, Ad Fontes Media, and Media Bias/Fact Check) rather than our own opinion. Its reliability rating of A reflects a strong track record of factual, well-sourced reporting. That rating is a guide for weighing what you read here, not a verdict on any single article.
We are currently tracking 8 recent articles from Financial Times, published over the past 2 hours.
The best way to use this profile is comparatively. Read Financial Times's coverage of a story alongside how outlets on other parts of the spectrum handle the same event — the facts usually overlap, but the emphasis, language, and what gets left out often do not. Other center sources we track include BBC News, Al Jazeera, Associated Press, and Reuters.
Recent Articles (8)
Nearly 100 US troops injured in two weeks since Iran war resumed
The Pentagon says most soldiers suffered ‘minor concussions’ and have returned to duty
Psychedelic drugs are going mainstream
Commercial success is looking less theoretical for treatments based on mushrooms and LSD
China weighs tighter export controls on AI models and chips
Beijing consults companies on ways to stop west acquiring its advanced technologies and star start-ups
The fall of America’s farm superpower
The US is on the verge of losing its status as the world’s leading agricultural exporter
Pointers for Burnham on what Britain really wants
The new prime minister can learn from 40 years of polling the UK population
AI is becoming a geopolitical weapon, warns EU digital chief
Europe needs to avoid relying on an unpredictable Washington for strategic capabilities, says Henna Virkkunen
Why Canada isn’t listening to American whining in the wine wars
Donald Trump’s tariffs have taught us an important lesson in the value of retaliation
Biotech deals surge to record as fear of missing out grips Big Pharma
Prospect of patents expiring on lucrative drugs prompts drugmakers to hunt for next blockbuster medicines